How proteomic insights and biobanks are powering the future of precision medicine
Yan Zhang, President of proteomic sciences at Thermo Fisher Scientific, writes about developments in precision medicine and how biobanks are key to … Read More
Yan Zhang, President of proteomic sciences at Thermo Fisher Scientific, writes about developments in precision medicine and how biobanks are key to … Read More
Many laboratories have invested in automation, yet workflows often remain fragmented, with disconnected instruments, data, and processes creating inefficiencies and limiting scalability. As scientific workflows grow more complex, automation alone is no longer enough. Leading labs are now embracing orchestration, the coordination of instruments, robotics, software, data, and people across the… Read More
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, researchers found an unexpected drug could help treat depression. Elsewhere, a new company is… Read More
News round-up for 16 – 20 February by Bruno Quinney, Content Team at DDW. This week in DDW, an unexpected drug could help treat depression. Elsewhere, a new company is set to advance a cerebral palsy therapy. The top stories: Psychedelic drug could help treat depression … Read More
A new regenerative medicine company is set to develop a novel cell and gene therapy targeting paediatric cerebral palsy (CP). Kidswell USA has been formed by a partnership between biosimilars and cell therapies company Kidswell Bio Corporation and corporate development advisor Treehill Partners. In the new company, Kidswell and Treehill aim to advance their… Read More
NVIDIA has announced a major expansion of NVIDIA BioNeMo, its open development platform for AI-driven biology and drug discovery, at the JP Morgan Healthcare Conference. The platform has expanded to include: New NVIDIA Clara open models, the RNAPro model for RNA structure prediction and the… Read More
Biotechnology company Thermo Fisher has announced plans to increase the impact of its growth strategy using artificial intelligence (AI) with OpenAI. Thermo Fisher believes the collaboration with OpenAI will help to improve the speed and success of drug development, enabling customers to get medicines to patients faster… Read More
Tech transfer is all about transferring technology, knowledge, and expertise from one phase of development to another, or from one facility to another, to ensure the successful replication and scaling up of biotherapeutic products. This involves several key activities such as knowledge and process transfer, process standardisation, quality and compliance,… Read More
Tech transfer is all about transferring technology, knowledge, and expertise from one phase of development to another, or from one facility to another, to ensure the successful replication and scaling up of biotherapeutic products. This involves several key activities such as knowledge and process transfer, process standardisation, quality and compliance,… Read More
This advertorial appeared in DDW Volume 25 – Issue 4, Fall 2024 Read the digital issue In a recent DDW event, supported by Thermo Fisher Scientific, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, presented his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. Cryo-EM… Read More
Bruntwood SciTech and Thermo Fisher Scientific have entered into a new strategic collaboration to support businesses across Bruntwood SciTech’s national portfolio of life science campuses, with a particular focus at their Alderley Park campus in Cheshire – the UK’s largest single site life science campus, which is home to… Read More
Join DDW for this exclusive free event, Scaling up in vitro transcription: Key results and considerations, which is supported by Thermo Fisher Scientific. In vitro transcription (IVT) can be a complicated reaction. Scaling up this process requires a good understanding of the various reaction parameters that… Read More
Join DDW for this exclusive free event, Scaling up in vitro transcription: Key results and considerations, which is supported by Thermo Fisher Scientific. In vitro transcription (IVT) can be a complicated reaction. Scaling up this process requires a good understanding of the various reaction parameters that… Read More
Join DDW for this exclusive free event, Scaling up in vitro transcription: Key results and considerations, which is supported by Thermo Fisher Scientific. In vitro transcription (IVT) can be a complicated reaction. Scaling up this process requires a good understanding of the various reaction parameters that… Read More
Join DDW for this exclusive free event, Scaling up in vitro transcription: Key results and considerations, which is supported by Thermo Fisher Scientific. In vitro transcription (IVT) can be a complicated reaction. Scaling up this process requires a good understanding of the various reaction parameters that… Read More
Join DDW for this exclusive free event, Scaling up in vitro transcription: Key results and considerations, which is supported by Thermo Fisher Scientific. In vitro transcription (IVT) can be a complicated reaction. Scaling up this process requires a good understanding of the various reaction parameters that… Read More